Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Topical Sulforaphane on Skin Aging and Light Exposure
NCT03730649Phase 1Active, not recruiting
- Sponsor
- Johns Hopkins University
- Start
- Oct 2019
- Primary completion
- Mar 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sulforaphane in Skin aging (2 arms), sponsored by Johns Hopkins University. Primary endpoints: Keratin 16 presence as determined by immunofluorescence assay up to 6 months, Keratin 17 presence as determined by immunofluorescence assay up to 6 months and 2 more. Started Oct 2019; status: active, not recruiting.
02
Drugs
sulforaphane
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT03730649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03730649.